Maze Therapeutics, Inc.
MAZE
DELAYED 1 MONTH

23 insider filings · Latest: Jul 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 29, 2026Jul 31 8:15 PMAtul DandekarCSBO
Sale
7,500$27.34$205.0K26,250(D)

View →

Jun 1, 2026Jun 3 9:04 PMJason V ColomaDirector, Chief Executive Officer
Sale
6,643$26.20$174.0K27,970(I)

View →

Jun 1, 2026Jun 3 9:01 PMHarold BernsteinPresident, R&D & CMO
Sale
14,853$25.66$381.1K0(D)

View →

May 29, 2026Jun 2 8:12 PMAtul DandekarCSBO
Sale
7,500$26.34$197.6K24,808(D)

View →

May 26, 2026May 27 8:16 PMJason V ColomaDirector, Chief Executive Officer
Sale
25,582$26.02$665.5K350,987(I)

View →

May 22, 2026May 27 8:16 PMJason V ColomaDirector, Chief Executive Officer
Sale
6,982$26.00$181.5K28,523(I)

View →

May 15, 2026May 18 9:07 PMJason V ColomaDirector, Chief Executive Officer
Sale
1,938$26.00$50.4K31,001(I)

View →

May 14, 2026May 18 9:03 PMHarold BernsteinPresident, R&D & CMO
Sale
15,000$26.22$393.4K0(D)

View →

Apr 29, 2026May 1 8:18 PMAtul DandekarCSBO
Sale
7,500$25.37$190.3K10,503(D)

View →

Mar 10, 2026Mar 12 8:51 PMHarold BernsteinPresident, R&D & CMO
Sale
30,000$50.45$1.5M0(D)

View →

Feb 27, 2026Mar 3 9:25 PMAtul DandekarCSBO
Sale
7,500$45.43$340.7K10,503(D)

View →

Mar 2, 2026Mar 3 9:20 PMAmy BachrodtSVP, Finance
Sale
5,000$45.20$226.0K12,965(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 29, 2026Jul 31 8:15 PMAtul DandekarCSBO
Option Exercise
7,500$10.4221,643(D)

View →

Jun 8, 2026Jun 10 8:31 PMDaniel K SpiegelmanDirector
Grant/Award
18,000$23.5818,000(D)

View →

Jun 8, 2026Jun 10 8:30 PMRichard H SchellerDirector
Grant/Award
18,000$23.5818,000(D)

View →

Jun 8, 2026Jun 10 8:28 PMJonathan E LimDirector
Grant/Award
18,000$23.5818,000(D)

View →

Jun 8, 2026Jun 10 8:26 PMHerve HoppenotDirector
Grant/Award
18,000$23.5818,000(D)

View →

Jun 8, 2026Jun 10 8:25 PMCharles J HomcyDirector
Grant/Award
18,000$23.5818,000(D)

View →

Jun 8, 2026Jun 10 8:23 PMNancy C AndrewsDirector
Grant/Award
18,000$23.5818,000(D)

View →

Jun 1, 2026Jun 3 9:01 PMHarold BernsteinPresident, R&D & CMO
Option Exercise
14,853$10.42207,554(D)

View →

May 29, 2026Jun 2 8:12 PMAtul DandekarCSBO
Option Exercise
7,500$10.4236,643(D)

View →

May 14, 2026May 18 9:03 PMHarold BernsteinPresident, R&D & CMO
Option Exercise
15,000$10.42222,407(D)

View →

May 4, 2026May 6 8:15 PMAtul DandekarCSBO
Option Exercise
14,305$10.4227,725(D)

View →

Apr 29, 2026May 1 8:18 PMAtul DandekarCSBO
Option Exercise
7,500$10.4244,143(D)

View →

Mar 10, 2026Mar 12 8:51 PMHarold BernsteinPresident, R&D & CMO
Option Exercise
30,000$10.42267,407(D)

View →

Mar 2, 2026Mar 3 9:30 PMMisbah TahirChief Financial Officer
Grant/Award
60,000$45.6120,000(D)

View →

Mar 2, 2026Mar 3 9:28 PMPhillips CourtneyGC and Corp. Secretary
Grant/Award
48,000$45.6116,000(D)

View →

Mar 2, 2026Mar 3 9:25 PMAtul DandekarCSBO
Grant/Award
57,000$45.6119,000(D)

View →

Feb 27, 2026Mar 3 9:25 PMAtul DandekarCSBO
Option Exercise
7,500$10.4259,143(D)

View →

Mar 2, 2026Mar 3 9:23 PMHarold BernsteinPresident, R&D & CMO
Grant/Award
72,000$45.6124,000(D)

View →

Mar 2, 2026Mar 3 9:20 PMAmy BachrodtSVP, Finance
Grant/Award
48,000$45.6116,000(D)

View →

Mar 2, 2026Mar 3 9:20 PMAmy BachrodtSVP, Finance
Option Exercise
5,000$10.4236,333(D)

View →

Page 1 of 2

Next →